Company intelligence / Profile preview

Medclair

Stockholm, Sweden
Ownership
Private
Employees
~15
Development stage
Other
01

Overview

Medclair is a Swedish medical technology company specializing in the collection and destruction of nitrous oxide (N2O), a potent greenhouse gas used extensively in healthcare for pain relief. The company provides a range of solutions, including mobile and central destruction units, as well as gas monitoring systems, to help hospitals reduce their carbon footprint and improve the working environment for staff. Their proprietary catalytic technology converts nitrous oxide into harmless nitrogen and oxygen with an efficiency rate exceeding 99%. Medclair's products are currently deployed in several European markets, with a significant presence in the UK's NHS, and are expanding globally to meet increasing environmental regulations. By addressing the climate impact of anesthetic gases, Medclair enables healthcare providers to maintain high standards of patient care while achieving sustainability goals.

Therapeutic areas
Other
Modalities
Device
Industry
Therapeutic Medical Devices
02

Partnerships

BOCLinde

Beyond the preview

Go deeper on Medclair.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Medclair.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call